Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments
| Status: | Archived |
|---|---|
| Conditions: | Colorectal Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | May 2010 |
| End Date: | August 2011 |
Pilot Study of CS-1008 in Combination With FOLFIRI (Irinotecan, Leucovorin, and 5-fluorouracil [5-FU]) in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Failed First-line Treatment That Was Not Irinotecan-based.
Treatment with CS-1008 in combination with FOLFIRI (irinotecan, leucovorin, and
5-fluorouracil [5-FU]) in subjects with metastatic colorectal cancer (CRC) who have failed
first-line treatment that was not irinotecan-based.
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials